TELO
Telomir Pharmaceuticals Inc
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Loading...
Open
4.90
Mkt cap
126M
Volume
131K
High
4.90
P/E Ratio
-5.44
52-wk high
20.72
Low
4.11
Div yield
N/A
52-wk low
3.11

Portfolio Pulse from Benzinga Newsdesk
February 09, 2024 | 4:06 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.